Influence of genetic variations in IL1B on brain region volumes in bipolar patients and controls. (February 2021)

• Record Type: Journal Article
• Authors: Strenn, Nina; Pålsson, Erik; Liberg, Benny; Landén, Mikael; Ekman, Agneta
• Is Part Of: Psychiatry research. Volume 296(2021)
• Publication Date: 2021-02
• Subjects: Interleukin-1 beta -- Putamen -- Bipolar disorder -- Magnetic resonance imaging -- Single nucleotide polymorphism; Psychiatry -- Periodicals; Psychiatry -- periodicals; Psychiatrie -- Périodiques; 616.89
• DOI: 10.1016/j.psychres.2020.113606
• Languages: English
• ISSNs: 0165-1781

Abstract

Highlights: IL1B variants associated with brain region volume in bipolar subjects and controls Genotype distribution did not differ between bipolar subjects and controls Supports role of the immune system mediator IL-1beta in brain structure Abstract: Involvement of the immune system has been implicated in the etiology and pathophysiology of mood disorders, including bipolar disorder. Neuroimaging studies have reported structural brain pathology in bipolar disorder patients, and both levels of and genetic variants in cytokines have been associated with altered volumes of brain regions. The aim of this study was to investigate associations between single nucleotide polymorphisms in the gene coding for the pro-inflammatory cytokine interleukin-1 beta ( IL1B ) and whole brain grey matter volume, as well as volumes of several brain regions shown to be of importance in mood disorders. Structural magnetic resonance imaging and vertex-based morphometry were used to obtain volume of different brain regions in subjects with bipolar disorder (n=188) and healthy controls (n=54). Four IL1B polymorphisms were genotyped: rs1143623, rs1143627, and rs16944 in the promoter region together with the synonymous variant rs1143634 in the IL1B gene. The genotype distribution did not differ between bipolar subjects and controls. The T allele at rs16944 and the C allele at rs1143627 were associated with increased volumes of the putamen of the left hemisphere in patients and controls, which lends support to the role of this immune system mediator for brain structure.